PubRank

D R Compton

Author PubWeight™ 48.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995 8.09
2 Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A 1999 3.54
3 Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 1996 2.90
4 Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 1991 2.57
5 The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 1994 2.55
6 Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 1998 1.97
7 Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 1997 1.87
8 Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther 1988 1.58
9 Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212. J Pharmacol Exp Ther 1994 1.52
10 Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 1998 1.37
11 Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J Med Chem 1996 1.19
12 Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs. Pharmacol Biochem Behav 1989 1.15
13 Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. J Pharmacol Exp Ther 1990 1.10
14 Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. Eur J Pharmacol 1996 1.09
15 Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J Pharmacol Exp Ther 1995 1.05
16 Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug Alcohol Depend 1994 0.93
17 Modeling the cannabinoid receptor: a three-dimensional quantitative structure-activity analysis. Mol Pharmacol 1991 0.93
18 Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC. Pharmacol Biochem Behav 1993 0.93
19 5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. J Med Chem 1992 0.91
20 Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sci 1995 0.87
21 Regulation of bacterial glycogen synthesis. Stimulation of glycogen synthesis by endogenous and exogenous cyclic adenosine 3':5'-monophosphate in Escherichia coli and the requirement for a functional CRP gene. J Biol Chem 1983 0.86
22 Pharmacological evaluation of halogenated delta 8-THC analogs. Pharmacol Biochem Behav 1991 0.86
23 Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. J Med Chem 1997 0.84
24 Investigation of the role of the phenolic hydroxyl in cannabinoid activity. Mol Pharmacol 1990 0.83
25 Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction. Drug Alcohol Depend 1995 0.83
26 Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids. NIDA Res Monogr 1987 0.82
27 Ontogeny of mu opioid agonist anti-nociception in postnatal rats. Brain Res Dev Brain Res 1998 0.80
28 Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol. Neuropharmacology 1996 0.79
29 A rational search for the separation of psychoactivity and analgesia in cannabinoids. Pharmacol Biochem Behav 1991 0.78
30 Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs). Bioorg Med Chem 1997 0.77
31 Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs. J Med Chem 1997 0.77
32 A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS. Life Sci 1995 0.76
33 Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist. J Med Chem 1994 0.76
34 Striatal synaptosomal dopamine synthesis: evidence against direct regulation by an autoreceptor mechanism. Eur J Pharmacol 1985 0.76
35 Pharmacological characterization of BNMPA (alpha-benzyl-N-methylphenethylamine), an impurity of illicit methamphetamine synthesis. Eur J Pharmacol 1996 0.75
36 (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution. Life Sci 1987 0.75
37 Modification of phencyclidine intoxification and biodisposition by charcoal and other treatments. Pharmacol Biochem Behav 1988 0.75
38 Free-radical inhibition of ATPase in hamster cheek pouch homogenates. Life Sci 1983 0.75